Ra Capital Management Reduces Position in Werewolf Therapeutics Amid Stock Decline
Ra Capital Management, L.P. and its affiliated funds have executed a series of sales totaling 678,226 shares of Werewolf Therapeutics, Inc. (NASDAQ:HOWL) between June 9 and June 11, 2026. The transactions, valued at $253,568, occurred as the biotech company's shares traded near their 52-week low of $0.35. Despite the fund's reduction, analysis indi…